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176Introduction: Female sexual dysfunction affects up to 43% of women in the United States and hypoactive sexual
desire disorder (HSDD) is the most common type; however, we lack treatment options showing improvement
for this condition.
Aims: To investigate whether acupuncture therapy could improve HSDD.
Methods: Premenopausal women with a primary diagnosis of HSDD were included in a single-arm prospective
pilot study that was approved by the institutional review board. After providing informed consent, subjects
completed validated questionnaires. Participants underwent 25-minute twice-weekly acupuncture sessions for 5
weeks with one certiﬁed acupuncturist. Questionnaires were completed again 6 weeks after onset of treatment.
Main Outcome Measures: Based on a statistically signiﬁcant change in the desire domain of the Female Sexual
Function Index from 2.0 (at baseline) to 2.4 (after intervention with a specialist) in our population of patients
diagnosed with HSDD, a sample of 13 was determined, with 90% power and a 0.05.
Results: Fifteen women were enrolled and 13 completed the study. Mean age was 36.9 ± 11.4 years. Most were
white (n ¼ 9, 60%), heterosexual (n ¼ 15, 100%), and non-smokers (n ¼ 14, 93%). Most were sexually active
more than four times per month (n ¼ 8, 53%) and none had a history of sexual abuse (n ¼ 15, 100%).
Participants received a mean acupuncture needle application of 17 ± 2 at each session. Sexual function improved
after intervention, particularly desire (2.1 ± 0.6 to 3.3 ± 1.2, P < .0001), arousal (P < .0001), lubrication
(P ¼ .03), and orgasm (P ¼ .005).
Conclusion: In this cohort of premenopausal women with HSDD, 5 weeks of acupuncture therapy was asso-
ciated with signiﬁcant improvements in sexual function, particularly desire. This supports a role for acupuncture
as a therapeutic option for women with low desire.
Sex Med 2016;4:e176ee181. Copyright  2016, The Authors. Published by Elsevier Inc. on behalf of the Inter-
national Society for Sexual Medicine. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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.org/10.1016/j.esxm.2016.02.005women.3 Although several approaches for management of this
medical condition have been suggested, standard options have
not demonstrated symptomatic improvement, and traditional
pharmacologic treatments have not been consistently helpful.4
Alternative therapies, such as acupuncture, are beneﬁcial in
treating a myriad of problems, such as urinary incontinence,
chronic lower back pain, and migraines.5e10
Acupuncture, as part of traditional Chinese medicine (TCM),
has existed for many centuries and is considered a safe procedure
when provided by a licensed practitioner.11 The skin is pene-
trated by sterile needles to stimulate speciﬁc points related to
three principal concepts of TCM: harmony between yin and
yang forces, qi (vital energy ﬂowing through the body), and the
ﬁve elements (ﬁre, earth, wood, metal, and water).11 Although
these concepts of TCM are not generally assessed in scientiﬁcSex Med 2016;4:e176ee181
Acupuncture for Hypoactive Sexual Desire Disorder e177studies, previous research evaluating the use of acupuncture for
medical conditions, such as male sexual dysfunction, has shown
good results.8 However, we are lacking similar evaluation of this
treatment modality for female sexual disorders.
AIM
We hypothesized that low libido for premenopausal women
with HSDD would improve with acupuncture therapy.
METHODS
This single-arm prospective cohort pilot study (institutional
review board approval number 12053-12-071; National Clinical
Trials registry identiﬁcation number NCT02070029) included
premenopausal women with a primary diagnosis of HSDD given
by a gynecologist or urogynecologist. Women 18 to 55 years old
were eligible if sexually active (deﬁned as at least four sexual
encounters in the month before enrollment), were in a monog-
amous relationship, and had a documented diagnosis of HSDD
as the primary cause of FSD (deﬁned as a non-adjusted score  6
in the desire domain [range ¼ 0e10] of the Female Sexual
Function Index [FSFI] questionnaire).12 Exclusion criteria
included postmenopausal women (deﬁned as absence of
menstruation in the prior 12 months), pelvic pain or dyspareunia
as the primary cause of FSD (deﬁned as a non-adjusted score  6
in the pain domain [range ¼ 0e10] of the FSFI), prior hyster-
ectomy and/or oophorectomy, history of chemotherapy and/or
pelvic irradiation, use of hormonal contraception or hormone
replacement therapy, active skin infection or disease preventing
insertion of acupuncture needles, known allergy to acupuncture
needles, or blood dyscrasia.
Potential participants were identiﬁed by recruitment posters in
the local clinic and by referral from their primary gynecologist or
after consultation with an urogynecologist. Subjects were screened
for eligibility by the primary investigators and, after informed
consent was obtained, baseline data were collected. Demographic
data included age (years), body mass index (kilograms per meter
squared), ethnicity, relationship status, sexual orientation (het-
erosexual, homosexual, bisexual), smoking status, medical
comorbidities, surgical history, obstetric and gynecologic history,
documentation of prior sexual trauma or abuse, and current
medications. In addition, enrolled and consented subjects were
interviewed by the certiﬁed acupuncturist (J.W.-L.) to determine
at least one TCM diagnosis related to female abdominal and pelvic
organs (kidney yang deﬁciency, liver qi stagnation, generalized
blood deﬁciency, spleen yang deﬁciency, and/or heart ﬁre),
because these are notmutually exclusive. Symptoms, appearance of
the tongue, palpation of peripheral pulses, and anatomicmeridians
factor into one’s TCM diagnosis. Each diagnosis is associated with
certain “external factors” and the pressure points indicated for
TCM acupuncture are speciﬁc to each diagnosis to relieve symp-
toms and prevent “external factors” from continuing to inﬂuence
the patient’s symptoms. Yang deﬁciencies are associated with
psychological stress and overwork. Qi stagnation is associated withSex Med 2016;4:e176ee181physical trauma and depression. Blood deﬁciency is associatedwith
emotional strain. Heat or heart ﬁre is associated with psychological
strain. Therefore, patients can be diagnosed with more than one
TCM pattern.
Functional Data
Five validated questionnaires were completed by all partici-
pants at enrollment and at 6 weeks after initiation of interven-
tion. The FSFI13,14 is a 19-item questionnaire that can be
administered in any age group and focuses on individual function
by six domains: desire, arousal, lubrication, orgasm, satisfaction,
and pain. Higher scores, with a possible maximum of 36, indi-
cate better sexual function, with scores no higher than 26.5
indicating sexual dysfunction.15 The Female Sexual Distress
ScaleeRevised (FSDS-R)16 is a 13-item questionnaire based on a
ﬁve-point Likert-type scale that provides a measurement of sexual
distress. The revised version includes a question that asks women
to rate distress related to HSDD. A score of at least 11 effectively
discriminates women with FSD from women without FSD. The
Short Form 12 (SF-12) is a 12-question validated survey about
one’s general health that assesses mental and physical compos-
ites.17 Each domain is given a weighted score, ranging from 0 to
100, with 50 considered comparable to the mean health of the
general U.S. population and 30 considered to be two SDs below
the general population’s health, indicating “below average”
health status. The General Anxiety-Disorder-7 (GAD-7) and
Prime Health Questionnaire-9 (PHQ-9)18 are a brief 16-item,
Likert-type questionnaires assessing the frequency of anxiety and
depression symptoms during the past 2 weeks. Each item is
assigned a score from 0 (not at all) to 3 (nearly every day), with a
score of 15 to 21 representing severe anxiety on the GAD-7 and a
score of 16 to 20 representing severe depression on the PHQ-9.
The World Health Organization Quality of Life BREF
(WHOQOL BREF)19 is an instrument comprised of 26 items
that measure the following four domains: physical health, psy-
chological health, social relationships, and environment; it is a
shorter version of the original instrument and is more convenient
for use in large research studies or clinical trials. Domain scores
denote subjects’ perception of their quality of life within that
domain and each is scaled positively, with higher scores repre-
senting higher quality of life. Mean item scores are added for a
domain score and then multiplied by 4 to remain comparable to
the 0 to 100 scoring on the WHOQOL-100 questionnaire.
There is no predetermined cutoff value; however, scores higher
than 50 indicate a better-perceived quality of life.Intervention
All participants underwent 25-minute twice-weekly acupunc-
ture sessions for 5 consecutive weeks (total¼ 10 sessions) with one
certiﬁed acupuncturist. Patients gave consent after being informed
of potential but rare risks of acupuncture, including, but not
limited to, soreness, bleeding, bruising, or irritation at the needle
site, infection, and internal organ damage from deeply placed
needles. The initial session included a detailed patient history with
Table 1. Demographics
Age (y), mean (SD) 36.87 (11.43)
BMI (kg/m2), mean (SD) 30.62 (6.83)
Gravida, mean (SD) 2.00 (1.78)
Vaginal births (n), mean (SD) 1.33 (1.45)
Cesarean births (n), mean (SD) 0.07 (0.26)
Acupuncture needles used per session (n),
mean (SD)
16.93 (2.31)
Ethnicity, n (%)
e178 Oakley et alroutine questions, in accord with the acupuncturist’s practice,
regarding dietary habits, level of diaphoresis, average water intake,
digestive function, sleep habits, and overall mood. In addition, the
acupuncturist inspected the patient’s tongue and palpated central
and peripheral pulses. These datawere not recorded but rather used
to formulate a TCM diagnosis, which was the single data point
recorded. Subsequent sessions included only the acupuncture
therapy without additional history or physical examination details
being obtained. The intervention was administered in a sterile
fashion using a predetermined range of needles (8e20) based on
the acupuncturist’s routine approach. Single-use MAC 30-gauge,
1- to 1.5-inch-long ﬁliform needles were supplied by a single
company (AAWellness Supply LLC, NewHyde Park, NY, USA).
The needles were placed along the scalp, nape of the neck, lower
back, lower abdomen, elbows, and/or knees depending on the
predetermined primary TCM diagnosis; however, participants
could have more than one TCM diagnosis. Therefore, location of
needle insertion was not part of the data collection process. While
the needles were left in place for 25 minutes, the patient was given
instructions to relax without moving and practice slow, deep
breathing exercises inside a dimly lit examination room with quiet
instrumental-based music playing in the background.White 9 (60.0)
Black 5 (33.3)
Asian 0 (0.0)
Other 1 (6.7)
Relationship status, n (%)
Married or involved 9 (60.0)
Single 5 (33.3)
Divorced 1 (6.7)
Widowed 0 (0.0)
Sexual orientation, n (%)
Heterosexual 15 (100.0)
Smoking status
Non-smoker 14 (93.3)
Smoker 1 (6.7)
Average sexual encounters (monthly), n (%)
4 7 (46.7)
5-8 5 (33.3)
9-12 2 (13.3)
>12 1 (6.7)
History of sexual trauma or abuse, n (%)
None 15 (100.0)
Medical conditions, n (%)
Diabetes 1 (6.7)Sample Size Calculation
Based on a statistically signiﬁcant change in the desire domain of
the FSFI from 2.0 (at baseline) to 2.434 (after intervention with a
specialist) in our population of patients diagnosed with HSDD, a
sample of 13 was determined.20 This calculation (N ¼ 13) has
90% power to detect a difference in means of 0.434 assuming an
SD of 0.434 using paired t-test with a 0.05 two-sided signiﬁcance
level. All calculations were performed using n-Query Advisor
(Statistical Solutions Ltd, Los Angeles, CA, USA).
Statistical analysis was performed using IBM SPSS Statistics
19.0 for Windows (IBM Corp, Armonk, NY, USA). Descriptive
statistics were calculated based on the general demographics of
subjects involved in the study, including TCM diagnosis and
number of acupuncture needles used. For functional (question-
naire) outcome data, ratings scales were treated as scale data and
differences between groups were compared using the Student
t-test for normally distributed data or the Wilcoxon signed rank
test for non-parametric data. Enrolled and consented participants
who completed the study received a $25 stipend.Asthma 1 (6.7)
Prolapse 2 (13.3)
Urinary incontinence 1 (6.7)
Depression 3 (20.0)
Chinese diagnosis, n (%)
Kidney yang 15 (100.0)
Liver qi 11 (73.3)
Generalized blood 0 (0.0)
Spleen yang 13 (86.7)
Heart ﬁre 1 (6.7)
BMI ¼ body mass index.MAIN OUTCOME MEASURES
The primary outcome was determined by a change in the
desire domain of the FSFI from baseline at enrollment to study
completion at 6 weeks after initiation of intervention.
Secondary outcome measurements were determined by func-
tional data points distributed at enrollment and 6 weeks: FSFI
total and domain scores, FSDS-R total score, SF-12 mental and
physical composite scores, GAD-7 and PHQ-9 total scores, and
WHO-QOL-BREF domain scores.RESULTS
Fifty women were screened for eligibility; 15 women were
enrolled and 13 completed the study after 2 were lost to follow-
up (mean age ¼ 36.9 ± 11.4 years; mean body mass index ¼
30.6 ± 6.8 kg/m2). Most were white (n ¼ 9, 60%), married
(n ¼ 9, 60%), heterosexual (n ¼ 15, 100%), and non-smokers
(n ¼ 14, 93%; Table 1). No woman reported a history of
polycystic ovarian syndrome or endometriosis. Two women re-
ported pelvic organ prolapse (13%) and one woman had urinary
incontinence (7%); however, no participant admitted to priorSex Med 2016;4:e176ee181
Acupuncture for Hypoactive Sexual Desire Disorder e179pelvic ﬂoor surgery. Most participants were sexually active at least
four times per month (n ¼ 7, 47%), ﬁve women reported ﬁve to
eight encounters per month (33%), and three women were active
at least nine times per month (20%). All participants denied a
history of sexual trauma or abuse (Table 1).
At baseline, participants reported a low mean FSFI desire
domain score (2.08 ± 0.59) demonstrating HSDD for study
inclusion. In addition, mean total FSFI score (19.43 ± 5.96) was
lower than 26.55 and mean total FSDS-R score (32.64 ± 12.76)
was higher than 11, indicating FSD. There were no other
noteworthy baseline questionnaires scores (Table 2).
All subjects (N ¼ 13, 100%) completed twice-weekly
acupuncture sessions for 5 consecutive weeks for a total of 10
sessions. All subjects were diagnosed with kidney yang deﬁciency
(n ¼ 15, 100%) and most also received a diagnosis of spleen
yang deﬁciency (n ¼ 13, 87%) or liver qi stagnation (n ¼ 11,
73%; Table 1). TCM diagnoses were not mutually exclusive.
Participants received a mean acupuncture needle application of
16.9 ± 2.3 at each session. There were no adverse events or
negative reactions to the acupuncture therapy.
At week 6, overall sexual function improved for the cohort
(Table 2). FSFI mean total score increased from 19.43 ± 5.96 toTable 2. Questionnaires
Baseline Week 6 P value*
FSFI (n ¼ 15), mean (SD)
Desire 2.08 (0.59) 3.28 (1.15) <.0001
Arousal 2.44 (1.12) 3.90 (1.30) <.0001
Lubrication 3.86 (1.80) 4.64 (1.39) .024
Orgasm 2.74 (1.49) 3.77 (1.43) .005
Satisfaction 3.23 (1.23) 4.06 (1.38) .099
Total score 19.43 (5.96) 25.45 (5.59) <.0001
FSDS-R (n ¼ 14),
mean (SD)
32.64 (12.76) 23.71 (14.06) .031
SF-12 (n ¼ 14), mean (SD)
MCS 47.55 (8.89) 50.35 (7.45) .152
PCS 54.72 (8.05) 54.81 (4.26) .875
GAD-7 (n ¼ 15),
mean (SD)
8.00 (10.00) 2.00 (5.24) .038
PHQ-9 (n ¼ 15),
median (IQR)
4.60 (3.89) 4.73 (4.93) .896
WHOQOL-BREF (n ¼ 15), median (IQR)
Perception of QOL 4.00 (1.00) 4.00 (1.00) —
Perception of health 4.00 (1.00) 4.00 (1.00) —
Health 17.14 (1.67) 16.72 (1.79) .174
Psychological 15.48 (2.31) 15.24 (1.97) .595
Social relationships 13.33 (2.67) 13.33 (4.00) .473
Environment 17.00 (1.50) 16.50 (2.00) .470
FSDS-R ¼ Female Sexual Distress SurveyeRevised; FSFI ¼ Female Sexual
Function Index; GAD-7 ¼ Generalized Anxiety Disorder 7; IQR ¼ inter-
quartile range; MCS ¼ mental composite score; PCS ¼ physical composite
score; PHQ-9 ¼ Prime Health Questionnaire 9; SF-12 ¼ Short Form 12;
WHOQOL-BREF ¼ World Health Organization Quality of Life, abbreviated
version.
*P < .05 is considered signiﬁcant.
Sex Med 2016;4:e176ee18125.45 ± 5.59 (P < .0001). Speciﬁcally, the FSFI desire domain
increased from 2.08 ± 0.59 to 3.28 ± 1.15 (P < .0001). Arousal
(P < .0001), lubrication (P ¼ .03), and orgasm (P ¼ .005) also
improved. Participants’ mean total FSDS-R score decreased from
32.64 ± 12.76 to 23.71 ± 14.06 (P ¼ .03), indicating less
distress related to their sexual symptoms. Regardless of this
improvement, scores remained higher than 11, which demon-
strated a continued sense of distress. Although GAD-7 scores at
baseline were not consistent with severe anxiety, there was a
signiﬁcant improvement after the intervention, from 8.00 ± 1.00
to 2.00 ± 5.24 (P ¼ .04). No other statistically signiﬁcant re-
lations were noted.
DISCUSSION
In this pilot study of a prospective cohort of premenopausal
women with HSDD, 5 weeks of acupuncture therapy was
associated with signiﬁcant improvement in low desire. Further-
more, overall sexual function, distress due to symptoms, and
general anxiety improved.
There are several proposed mechanisms of action for acupunc-
ture. Older research reported a release of endorphins during
therapy sessions,21,22 whereasmore recent literature has focused on
the physiologic effects of these endorphins on the brain as seen at
functional magnetic resonance imaging.23e26 However, our study
did not include laboratory data or brain imaging. Instead, we
focused on symptomatic improvement. Acupuncture is widely
used and has been studied as treatment for several chronic medical
conditions, from migraines27 and pelvic pain syndromes such as
dysmenorrhea28,29 to urinary incontinence9 and fertility issues,30
with improvement in patient symptoms. Similarly, we noted
improvement in our subjects’ symptoms, primarily that of low
sexual desire. After intervention with acupuncture, we noted a
much greater difference in our primary outcome measurement
than was anticipated by our power analysis, which was based on
intervention by specialist consultation alone. This could illustrate
that acupuncture has a positive impact.
In general, most studies evaluating the efﬁcacy of acupuncture
assess patient symptomatology rather than hormone levels.
Lammerink et al31 focused on the outcome measurements of self-
reported hot ﬂashes and impaired sexual functioning from breast
cancer treatments after intervention with acupuncture. De Valois
et al32 found improved vasomotor symptoms after acupuncture
therapy. Our study focused on symptomatic improvement using
validated questionnaires for a more robust assessment of change.
Nonetheless, some rat model studies by Wang et al33,34 evaluated
hypothalamic function after activation by acupuncture and
showed increased electrical activity of excitatory neurons related
to stimulation of sexual arousal. Although we did not use an
animal model, our population included reproductive-age women
similar to the research of Wang et al and our subjects reported
increased sexual arousal. In addition, our study design focused on
a single prospective cohort, similar to the research by De Valois
et al, and included premenopausal women. However, the
e180 Oakley et alparticipants in the study by De Valois et al were taking tamox-
ifen, which could have inﬂuenced hormonal status regardless of
age, and our study design controlled for this.
Research is lacking regarding the use of acupuncture for FSD.
A systematic review from 20118 conﬁrmed that the evidence was
insufﬁcient for drawing any positive conclusions about the
application of acupuncture to improve FSD. In addition, the
review concluded there was a considerable risk of bias. In
contrast, our study found positive improvements in FSD and our
methodology included stringent exclusion criteria. More recent
research by Khamba et al35 in 2013 examined the beneﬁt of
acupuncture to manage sexual dysfunction secondary to antide-
pressant use. Although men and women of different ages were
included, improvements were noted in libido and lubrication for
the women. Interestingly, our study saw improvements in libido
and lubrication with only 10 consecutive acupuncture sessions,
whereas the protocol used by Khamba et al used 12. Further-
more, our study showed a modest decrease in symptom-related
distress similar to the decrease of anxiety and depression in the
subjects described by Khamba et al.
The strengths of this study are its prospective nature, use of
validated questionnaires, and use of a single certiﬁed acupunc-
turist. To standardize our study population, perimenopausal
and postmenopausal women, typically those most affected with
HSDD, were excluded to decrease any inﬂuence of variable
hormone levels on level of sexual desire. Nonetheless, there
were limitations. The generalizability of our study is limited by
our stringent exclusion criteria. Also, because it is difﬁcult to
doubly blind this type of study to the acupuncturist, we did not
include a sham treatment group for comparison. In addition,
acupuncture therapy is speciﬁc to the patient’s symptoms, not
to a “Western” medical condition. Therefore, although all
participants had HSDD, there was some variation among
needle combinations and application sites at each session,
depending on the type of TCM diagnoses given. Studies of this
nature also have inherent selection bias, and participants had to
be willing to undergo several weeks of treatment, which
complicated enrollment. Moreover, we did not control for di-
etary inﬂuence, level of daily exercise, use of antidepressants, or
other alternative therapies such as pelvic ﬂoor physical therapy
and massage.
In conclusion, there is a paucity of clinical evidence evaluating
the use of acupuncture for FSD despite its application in other
chronic health conditions. This preliminary study supports a role
for acupuncture as a therapeutic option for women with sexual
dysfunction, particularly low desire; however, further research
including a sham treatment arm could be beneﬁcial to determine
the signiﬁcance of our results.
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